NDC 78670-140

Zimhi

Naloxone Hydrochloride

Zimhi is a Intramuscular; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Uswm, Llc. The primary component is Naloxone Hydrochloride.

Product ID78670-140_11da80e4-2e84-40e0-aa63-6f7d5b58405e
NDC78670-140
Product TypeHuman Prescription Drug
Proprietary NameZimhi
Generic NameNaloxone Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; SUBCUTANEOUS
Marketing Start Date2022-03-15
Marketing CategoryNDA /
Application NumberNDA212854
Labeler NameUSWM, LLC
Substance NameNALOXONE HYDROCHLORIDE
Active Ingredient Strength5 mg/.5mL
Pharm ClassesOpioid Antagonist [EPC], Opioid Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 78670-140-02

2 SYRINGE in 1 CARTON (78670-140-02) > .5 mL in 1 SYRINGE (78670-140-11)
Marketing Start Date2022-03-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Zimhi" or generic name "Naloxone Hydrochloride"

NDCBrand NameGeneric Name
0093-2165Naloxone HydrochlorideNaloxone Hydrochloride
0404-9920Naloxone HydrochlorideNaloxone Hydrochloride
0404-9921NALOXONE HYDROCHLORIDEnaloxone hydrochloride
0404-9922NALOXONE HYDROCHLORIDEnaloxone hydrochloride
0404-9923NALOXONE HYDROCHLORIDEnaloxone hydrochloride
0409-1215Naloxone HydrochlorideNALOXONE HYDROCHLORIDE
0409-1219Naloxone HydrochlorideNALOXONE HYDROCHLORIDE
0409-1782Naloxone HydrochlorideNALOXONE HYDROCHLORIDE
0641-6205Naloxone HydrochlorideNaloxone Hydrochloride
17478-041Naloxone HydrochlorideNaloxone Hydrochloride

Trademark Results [Zimhi]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZIMHI
ZIMHI
88281598 not registered Live/Pending
Adamis Pharmaceuticals Corporation
2019-01-29
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.